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ABSTRACT
he rampant spread of COVID-19
outbreak, across borders and
geographies, has severely impacted
almost the whole world and triggered
significant downside risks to the overall
global economic outlook. Due to the
lockdown announced by the Indian
Government, the economy may slow
over the next few months. For most
businesses, the slowdown could be in
the form of supply disruptions, fall in
consumption demand, and stress on
the banking and financial sectors. There
has been distress in many sectors. It
was also observed that this pandemic
situation could boost business in sector
and may highly affect some sectors.
There observed a mixed response in
Pharmaceutical sector. Some experts
predicted positive impact however few
pharmaceutical companies reported
loss during this period. This created
a curiosity to test the performance of
pharmaceutical companies with their
stock price as performance indicator.
We propose to consider the sample
period as first nationwide lockdown
date to June 30, 2020. Closing price
of selected companies share price
will be considered in the study and
we use econometric test to test the
performance.
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INTRODUCTION
An unknown disease (n- Cov 19) which
is spreading worldwide is affecting
the people and also the economy
very badly. This Corona virus initially
was found in a small area of china in
last year December 2019 and slowly
started grow rapidly around more than
175 countries in the world. The virus
is highly communicable in nature so
to cease the virus various measures
are imposed as a National shut down,
Air traffic control, People adhered to
wear a mask, avoid being in a crowded
places, class contact conversation and
to sanitize themselves frequently.
Although the first instance of corona
in India was evidenced on January
30th 2020, the spread of virus is
rapid in the current scenario has been
one of the largest democratic nation
around the world, The sectors like
Trade, Travel, Tourism, Entertainment,
Hotels, Airlines is adversely affected
in the economy.
The Outbreak of the COVID-19 had
created many new challenges globally,
one of the major challenges is to lift
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the economy loss, due to which many
pharmaceutical industries started to
innovate a new vaccine for the deadly
disease. The pharmaceutical sector
has witnessed a mixed result during
this pandemic, but many companies
are unable to meet the requirements of
supply on time. Healthy environment
creates a balanced economy, so that
the government is working hard to
improve the medical emergency.
As per the latest analysis, current
scenario had benefited the Indian
Pharmaceutical sector by increasing
Global Investments, Cost regulation,
Economic drivers, Policy support etc.
The immediate decision of lockdown in
a country had worst affected the people
of wage labourers, the below poverty
group and the unskilled employees.
The corona virus has resulted towards
an economic recession all over the
world, due to which export and
import, manufacturing activities, GDP
had undergone a drastic decline. This
recession period had affected the people
both mentally and physically, which
had broke their confidence of living and
the fear for the future decisions. The
government is constantly supporting
for the Research and Developmental
(R&D) activities in pharmaceutical
sector; hence the pharmaceutical
industry was able to open the lines of
communication to uplift the medical
emergency through enhancing patient
engagement, introducing commercial
strategies in the supply of medication
demand. On continuing the Govt.
introduces a set of regulations like
Educational institutions, Metro and
Air traffic, Sports and Entertainment
activities to be closed or restricted.
Thus the pharmaceutical industry is
becoming the new operating model in
the society.
REVIEW OF LITERATURE
(Ritwik and Singh, 2020)describes
the impact of COVID 19 on different
sectors, schemes and policies on the

government announced and how to
uplift the Indian economy. The data
used in the study are collected from the
primary and secondary information,
the demographic analysis is made
based on the primary data, with a
sample size of 119 individuals. These
data is represented through tables,
pie charts & dichotomous questions.
Spurning
Chinese
products
and
focusing on Indian products may be
an overcome for the Indian economy.
Therefore, COVID 19 could be termed
as a opportunity to rediscover India.
(Ray et al., 2020) studied the short and
long term clash of an initial lockdown
on the total number of COVID-19
cases in India by comparing to other
interceding non- pharmaceuticals.
They have used epidemiological
forecasting models to estimate the
effects of philosophical durations of
lockdown which studies the substitute
explanations for slower growth rate of
COVID outbreak in India. They have
used present data on daily basis of
cases from India. These data has been
analysed using a extended version of
standard SIR model. So finally this
study tells that lock down comes with
a tremendous change in price which
will have major impact in social and
economic health in Indian economy.
(Raj and Bahl, 2020) discussed about
the impact of COVID on many sectors
of the economy, like the GDP growth
levels, Unemployment rate, sector
wise Increase or Decrease in sales etc.
The paper highlights on the pandemic
situation in India, the data is collected
from the secondary sources through
magazines, publications and also used
a different analysis. But at last the virus
as improved public health services,
in spite of spreading a virus, it has
been given for the nation to develop
infrastructure of health, developed a
cleanliness, improved technology in
overall framework of organisation.
(GUMBER
and
BULSARI,
2020)
described that unknown virus which
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is creating a pandemic situation in
the world, where India is also getting
affected by the COVID 19, this virus
as created an impact not only on
economy but also on human health,
various sector is affected with a
nationwide lockdown, many sectors
are worst affected. But few industries
are working essential commodities to
combat from decease. The people are
getting affected by COVID as well as by
technology innovations due to which
unskilled people are losing the hope to
sustain in the world; many have lost
their lives and life.
(Warjri and Shah, 2020)talks India’s
and Africa’s Health with larger
population, where both the countries
are lacking with the facilities and
investments. This paper reveals about
the effect of Novel Corona virus in both
countries. The data is collected from
a secondary source, here the data
reveals about the affected people per
million. This pandemic situation both
the governments as taken a measures
and introduce a new measures and
policy in health sector, This virus as
created a stepping for many changes
in the government to provide an
opportunity for private sector and
helping the society to reshape a for a
future pandemics.
(Aravind and Manojkrishnan, 2020)
describes
how
n-Cov
affected
pharmaceutical stocks listed with the
National Stock exchange of India. Here
this paper gives us an idea about the
stock variation of different company
and give us the figure of growth
and decline. The data used here is
secondary, information used in the
study are collected from Daily return
from NSE considering 10 companies.
The statistical formulation is used to
analyse the variation. This report on
pharmaceutical stocks results with
COVID 19 as also affected a medical
industry as well. This study suggests

investing on a R&D activities and
encouraging an Indian pharmaceutical
sector results a future benefit.
(Gunaseelan and Kesavan, 2020)talks
the current crisis on business and
economics in India during the Corona
virus. The article highlights about the
idea to recovery of losses occurred
during this pandemic situation. The
data is collected from the secondary
sources; here this article suggests
some ideas about revenue collection
for the government to improve the
national income. The central and state
government should work in an effective
manner to overcome the situation and
people should also follow rules and
policies of the government.
(Raut, 2020)describes about the
current condition of COVID 19 in the
World, and also the financial crisis
taking place in Indian economy due to
which the country is bearing a huge
loss. The virus is not only affecting
our country but many countries are
also suffering; every country started
to innovative a vaccine for the virus,
where government is supporting
for the action. The data is collected
through secondary source through
journals, website etc. This paper is
based only the secondary data. Many
sectors are affected in the economy,
but government has taken measures to
overcome from the spreading of virus.
The government is giving facilities for
people to help them in the pandemic.
(Agrawal, Jamwal and Sumit, 2020)
discusses impact of n-Cov 19 on Indian
market and distribution channel in
India, 18 threats are been founded
which affects the distribution. Due
to sudden lockdown decision the
economic activities have reduced,
which results towards the unexpected
fall in the market. Workforce, products,
costs these are the fields which are
affected from virus. In the country like
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India corona virus as created a huge
disturbance in the global market for
manufacturing and exchange activities.
Here, by the statistical tool the data
is drawn and analysed. COVID 19 is
affecting the manufacturing as well the
supply chain sector, to overcome from
the barrier many techniques, theories
and models is available to come out of
the problem.
(Jain, Baghla and Aditya, 2020)talks
the COVID 19 impact on agricultural
sector, here they are pointing it out the
problem of a farming activities due to
national lockdown; created a problem
of transportation, labors availability
etc; the disease is harming for a Rabi
season harvest all over the nation.
Here is data is collected from secondary
source through worldometer. By a
short span of time virus has been
destroyed financial stability all over the
globe, India as taken many measures
to encourage a MSE’s. In spite of
these panic period Export activities
is running, government should take
necessary action about agriculture
sector to help the farmers to sell their
products.
(Maloney and Temel Taskin, 2020)
discusses
the
social
distancing
among the nation help to minimize
the virus, where Non-pharmaceutical
Interventions (NPI’s) as to be adopted
by the public voluntarily to reduce
the spreading of decease. In spite
of these measures social distancing
and by many restrictions there is a
less mitigation happened. The data is
collected through COVID community
mobility reports, structured using a
tables and graphs. As an introduce of
NPI many developing countries also
got a beneficial by taking protective
measures and people to feel confidence
to move out, Many countries voluntarily
started to apply this method.
RESEARCH GAP
COVID-19 and its impact on economy
is an ongoing research which is seeking

huge concentration and importance. It
is very essential to assess the impact
of selected sectors due to COVID-19.
Pharmaceutical sector is being one
such dynamic one which contributes
to relatively important levels to
Indian economy. Various researchers,
economists and industrialists observed
that Pharmaceutical sector is the highly
regarded and progressive sector.
Profits and earnings of this sector
were predicted to be positive and
appreciating. This created curiosity to
find the actual performance of Indian
pharmaceutical sector.
OBJECTIVE
•
To determine the significant
relationship between Indian stock
market Index & Indian pharmaceutical
Index due to COVID-19.
METHODOLOGY
Research Design & Hypothesis:
Causal research design is used in the
study where the objective is to identify
the variables and analyse if a cause
and effect impact exists among them,
and if so, to quantify the extent of the
impact. The variables in this study are
Stock Market Index and Pharma Index.
The approach used in this study for
hypothesis testing is the classical or
sampling theory approach where the
hypothesis is accepted or rejected
on the basis of sampling information
alone. Any sample might vary from
its population and so it is important
to judge whether the result from the
sample is statistically significant or
not. To test the significance null (H0)
and alternate hypotheses (H1) are
used.
The Hypotheses for the study are:
H0: There is no significant relationship
between Indian stock market Index &
Indian pharmaceutical Index due to
COVID-19.
H1: There is a significant relationship
between Indian stock market Index & Indian
pharmaceutical Index due to COVID-19.
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Sampling design:
The population considered for the
study is the index values of Indian
pharma and stock markets. Nonprobability
sampling
design
is
adopted to select a sample from the
population of Indian stock market
Index & Indian pharmaceutical Index
due to COVID-19.
Data used:
The study relies mainly on secondary
data. The secondary data used for
the purpose of study are the closing
prices of the Nifty 50 and Nifty
Pharmafrom the nationwide lockdown
period starting from March 24, 2020

to June 30, 2020. These values are
used to calculate the relationship and
causality.
Data analysis techniques:
The
following
Statistical
and
Econometric Techniques are used for
data analysis.
•
•

Descriptive Statistics
Augmented Dickey-Fuller Unit
Root Test
•
Normality Test
•
Correlation Test
•
Ordinary Least Square Test
DISCUSSIONS AND ANALYSIS
Descriptive Statistics

NIFTY_50

NIFTY_PHARMA

Mean

9394.680

9224.825

Median

9270.900

9386.200

Maximum

10471.00

10360.80

Minimum

7801.050

6611.050

Std. Dev.

628.7951

977.9311

Skewness

-0.194869

-1.514196

Kurtosis

2.454375

4.391579

Jarque-Bera

1.217671

30.08323

Probability

0.543984

0.000000

Sum

610654.2

599613.6

Sum Sq. Dev.
Observations

25304527
65

61206346
65
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Descriptive statistics helps us with the data frequency and its characteristics. From
the above analysis it is observed that both the variables have fair levels of data
frequency. However with respect to Standard deviation, Kurtosis, Jarque-Bera and
Probability levels, Nifty Pharma displays better data characteristics compared to
Nifty 50.
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Ordinary Least Squares test reveals the regression level for the variables. The
Bivariate regression analysis used in the study shows that the there is a reasonable
impact between Nifty 50 and Nifty Pharma. Stock market index impacts the
performance of Pharma sector and coefficient value 56 percentage signifies the level
of impact. Also the values are significant. Both R-squared and Adjusted R-squared
values are above 75 percentage which shows that study is reliable and satisfies the
predicting requirements.
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The above graph shows the comovement between stock market
and pharma sector. The graph shows
that both the variables follow similar
pattern of movements. This is suitable
to infer that both stock market and
pharma sector follows similar trend
during COVID-19
CONCLUSION
From the above analysis it is found
that Indian Stock Market and Pharma
sector has positive and strong
relationship and further it is observed
that they are highly impacted among
each other during COVID-19. This
result further reveals that both
variables move together which
proves a co-movement relationship.
Any impact or corrections in stock
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market will reflect an immediate
and equal impact in Pharma sector
during COVID-19.
It is suggested to investors to pay
attention towards Indian stock
market if they are finding an
opportunity in Pharma investments.
Further Pharma investments can
be considered as an alternative
investment instrument to Nifty 50
during the COVID-19 period.
This knowledge of Stock market and
Pharma co-movement will be more
beneficial for portfolio managers
and traders those aspire to have a
diversified portfolio and mitigate the
risk on price volatility.
The results and recommendation are
arrived only based on sample data.
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